Experimental Basis of New Therapeutic Approaches to Septic Shock
- 1 January 1992
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Role of Antibodies and Antibiotics in Aerobic Gram-Negative Septicemia: Possible Synergism Between Antimicrobial Treatment and ImmunotherapyClinical Infectious Diseases, 1991
- Antibodies to Core Lipopolysaccharide Determinants: Absence of Cross-reactivity with Heterologous LipopolysaccharidesThe Journal of Infectious Diseases, 1991
- Presence of the Inflammatory Cytokines IL-1, TNF, and IL-6 in Preparations of Monoclonal AntibodiesHybridoma, 1989
- Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.The Journal of Experimental Medicine, 1989
- Specificity and Cross-Reactivity of Monoclonal Antibodies Reactive with the Core and Lipid A Regions of Bacterial LipopolysaccharideThe Journal of Infectious Diseases, 1989
- Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.Journal of Clinical Investigation, 1988
- Effect of High-Dose Glucocorticoid Therapy on Mortality in Patients with Clinical Signs of Systemic SepsisNew England Journal of Medicine, 1987
- A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 1987
- Endotoxins, Arachidonic Acid, and Superoxide FormationClinical Infectious Diseases, 1987
- Antibiotic-induced bacterial cell lysis: A therapeutic dilemmaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986